Mitochondrial impairment and rescue in riboflavin responsive neuropathy
| Autor: | Iain P. Hargreaves, Renata S Scalco, Simon Pope, Patrick F. Chinnery, Mary M. Reilly, Zane Jaunmuktane, Andrew B. Singleton, Balasubramaniem Ashokkumar, Charles Marques Lourenço, James E.C. Jepson, Andrey Y. Abramov, Vincenzo Salpietro, Andreea Manole, Camilo Toro, Tamas Revesz, Thomas S. Jacques, Marthe H.R. Ludtmann, Dimitri M. Kullmann, Rita Horvath, Alejandro Horga, Amelie Pandraud, Michael G. Hanna, Francesco Muntoni, Henry Houlden, Simon Heales, Abi Li |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
Genetics
0303 health sciences medicine.medical_specialty Gene knockdown Ataxia Mitochondrial disease Neuropathology Biology medicine.disease Spinal cord 3. Good health 03 medical and health sciences 0302 clinical medicine Endocrinology Atrophy medicine.anatomical_structure Riboflavin transport Internal medicine medicine Brainstem medicine.symptom 030217 neurology & neurosurgery 030304 developmental biology |
| DOI: | 10.1101/110890 |
| Popis: | Brown-Vialetto-Van Laere syndrome (BVVLS) represents a phenotypic spectrum of motor, sensory, and cranial nerve neuropathy, often with ataxia, optic atrophy and respiratory problems leading to ventilator-dependence. Loss-of-function mutations in two riboflavin transporter (RFVT) genes, SLC52A2 and SLC52A3, have recently been linked to BVVLS. However, the genetic frequency, neuropathology and downstream consequences of RFVT mutations have previously been undefined. By screening a large cohort of 132 patients with early-onset severe sensory, motor and cranial nerve neuropathy we confirmed the strong genetic link between RFVT mutations and BVVLS, identifying twenty-two pathogenic mutations in SLC52A2 and SLC52A3, fourteen of which were novel. Brain and spinal cord neuropathological examination of two cases with SLC52A3 mutations showed classical symmetrical brainstem lesions resembling pathology seen in mitochondrial disease, including severe neuronal loss in the lower cranial nerve nuclei, anterior horns and corresponding nerves, atrophy of the spinothalamic and spinocerebellar tracts and posterior column-medial lemniscus pathways. Mitochondrial dysfunction has previously been implicated in an array of neurodegenerative disorders. Since riboflavin metabolites are critical components of the mitochondrial electron transport chain (ETC), we hypothesized that reduced riboflavin transport would result in impaired mitochondrial activity, and confirmed this using in vitro and in vivo models. ETC complex I and complex II activity were decreased in SLC52A2 patient fibroblasts, while global knockdown of the single Drosophila RFVT homologue revealed reduced levels of riboflavin, downstream metabolites, and ETC complex I activity. RFVT knockdown in Drosophila also resulted in severely impaired locomotor activity and reduced lifespan, mirroring patient pathology, and these phenotypes could be partially rescued using a novel esterified derivative of riboflavin. Our findings indicate mitochondrial dysfunction as a downstream consequence of RFVT gene defects in BVVLS and validate riboflavin esters as a potential therapeutic strategy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|